AKI KDIGO 2/3 | KDIGO 0/1 | p-Value | |
---|---|---|---|
(n = 8) | (n = 32) | ||
Age [years] | 81.4 ± 4.2 | 80.7 ± 5.9 | n.s. |
Male gender [n (%)] | 3 (37.5) | 13 (40.6) | n.s. |
Weight [kg] | 76.6 ± 13.6 | 70.2 ± 11.2 | n.s. |
Height [cm] | 167.3 ± 6.6 | 164.7 ± 8.5 | n.s. |
Preoperative creatinine [mg/dl] | 1.18 ± 0.26 | 1.12 ± 0.24 | n.s. |
Preoperative eGFR [ml/min/1.73 m2] | 65.6 ± 15.9 | 65.9 ± 18.1 | n.s. |
Transapical approach [n (%)] | 6 (75.0) | 28 (87.5) | n.s. |
SAPS | 33.8 ± 9.7 | 27.0 ± 6.7 | 0.034 |
TISS | 23.0 ± 4.5 | 22.6 ± 4.5 | n.s. |
LVEF [%] | 49.3 ± 16.9 | 49.3 ± 10.9 | n.s. |
AVA [cm2] | 0.83 ± 0.32 | 0.69 ± 0.22 | n.s. |
MPG [mmHg] | 36.8 ± 23.5 | 42.9 ± 17.2 | n.s. |
Comorbidities [n (%)] | n.s. | ||
Hypertension | 7 (87.5) | 24 (75.0) | n.s. |
PHT | 1 (12.5) | 5 (15.6) | |
Smoking | 2 (25.0) | 8 (25.0) | n.s. |
Diabetes | 3 (37.5) | 10 (31.3) | n.s. |
COPD | 4 (50.0) | 6 (18.8) | n.s. |
Atrial fibrillation | 7 (87.5) | 13 (40.6) | 0.031 |
Peripheral artery disease | 1 (12.5) | 11 (34.4) | n.s. |
Recent myocardial infarction | 2 (25.0) | 2 (6.3) | n.s. |
CAD | 5 (62.5) | 19 (59.4) | n.s. |
Duration of surgery [h] | 84.09 ± 0.03 | 84.06 ± 0.02 | n.s. |
Contrast agent [ml] | 102.1 ± 35.8 | 131.0 ± 44.7 | n.s. |
Fluid balance on the day of surgery [ml] | 2950. 0 ± 1053.8 | 2239.3 ± 954.6 | n.s. |
Cumulative catecholamine dosage on the day of surgery [μg/kgBW/min] | 0.12 ± 0.09 | 0.06 ± 0.08 | n.s |
LCOS [n (%)] | 1 (12.5) | 0 (0) | n.s. |
Sepsis [n (%)] | 2 (25.0) | 0 (0) | 0.03 |
Septic shock [n (%)] | 1 (12.5) | 0 (0) | n.s. |
LOS ICU/IMC [d] | 8.3 ± 4.9 | 4.9 ± 3.8 | n.s. |
Outcomes According to VARC-2 [n (%)] | |||
30-d-mortality all cause | 1 (12.5) | 1 (3.1) | n.s. |
30-d-mortality cardiovascular | 1 (12.5) | 0 (0) | n.s. |
Stroke/TIA 30 d | 0 (0) | 1 (3.1) | n.s. |
Bleeding | |||
Life-threatening/disabling | 1 (12.5) | 0 (0) | n.s. |
Major | 0 (0) | 0 (0) | n.s. |
Minor | 0 (0) | 0 (0) | n.s. |
Unplanned use of CPB | 0 (0) | 0 (0) | n.s. |
Conversion to open surgery | 0 (0) | 0 (0) | n.s. |
Pacemaker implantation | 1 (12.5) | 0 (0) | n.s. |
Myocardial infarction | 0 (0) | 0 (0) | n.s. |
Procedure success | 8 (100) | 32 (100) | n.s. |
Access site complications | |||
minor | 0 (0) | 0 (0) | n.s. |
major | 0 (0) | 0 (0) | n.s. |